X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47681) 47681
Publication (4302) 4302
Newsletter (842) 842
Book Review (793) 793
Book Chapter (370) 370
Book / eBook (315) 315
Conference Proceeding (84) 84
Dissertation (48) 48
Magazine Article (28) 28
Data Set (10) 10
Newspaper Article (7) 7
Reference (6) 6
Web Resource (5) 5
Paper (4) 4
Transcript (4) 4
Government Document (3) 3
Trade Publication Article (3) 3
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29672) 29672
male (24312) 24312
index medicus (23311) 23311
stroke (17572) 17572
female (17188) 17188
animals (13892) 13892
clinical neurology (13638) 13638
neurosciences (13354) 13354
middle aged (12674) 12674
aged (11941) 11941
adult (8100) 8100
rats (8032) 8032
ischemia (7998) 7998
brain (7503) 7503
neurology (6908) 6908
treatment outcome (6514) 6514
risk factors (6067) 6067
cerebral infarction (5637) 5637
magnetic resonance imaging (5473) 5473
surgery (5391) 5391
cerebral ischemia (5185) 5185
peripheral vascular disease (4900) 4900
disease models, animal (4804) 4804
aged, 80 and over (4729) 4729
time factors (4189) 4189
rats, sprague-dawley (3886) 3886
analysis (3761) 3761
neuroprotection (3727) 3727
care and treatment (3710) 3710
research (3656) 3656
retrospective studies (3559) 3559
brain - pathology (3541) 3541
tomography, x-ray computed (3388) 3388
mice (3379) 3379
focal cerebral-ischemia (3378) 3378
infarction (3213) 3213
medicine & public health (3209) 3209
brain ischemia - drug therapy (3140) 3140
mortality (3027) 3027
therapy (2939) 2939
health aspects (2930) 2930
cerebral-ischemia (2880) 2880
cerebral angiography (2787) 2787
prognosis (2756) 2756
brain ischemia - pathology (2686) 2686
acute ischemic-stroke (2622) 2622
pharmacology & pharmacy (2578) 2578
radiology, nuclear medicine & medical imaging (2577) 2577
stroke - drug therapy (2568) 2568
apoptosis (2551) 2551
neuroimaging (2465) 2465
inflammation (2461) 2461
cerebral blood flow (2451) 2451
article (2443) 2443
patients (2352) 2352
follow-up studies (2299) 2299
cardiovascular diseases (2298) 2298
diagnosis (2297) 2297
risk (2273) 2273
neurosurgery (2254) 2254
reperfusion (2253) 2253
ischemic stroke (2219) 2219
subarachnoid hemorrhage (2218) 2218
stroke - etiology (2212) 2212
prospective studies (2210) 2210
adolescent (2195) 2195
thrombolysis (2167) 2167
hemorrhage (2162) 2162
neuroprotective agents - pharmacology (2145) 2145
medicine (2135) 2135
neurons (2077) 2077
stroke - pathology (2070) 2070
disease (2069) 2069
rats, wistar (2050) 2050
brain ischemia - physiopathology (2047) 2047
oxidative stress (2046) 2046
stroke - physiopathology (2040) 2040
cerebral infarction - etiology (1992) 1992
thrombolytic therapy (1971) 1971
rodents (1969) 1969
hypertension (1965) 1965
stroke - therapy (1962) 1962
neuroprotective agents - therapeutic use (1924) 1924
injury (1898) 1898
medical research (1872) 1872
management (1812) 1812
intracerebral hemorrhage (1800) 1800
injuries (1797) 1797
expression (1796) 1796
occlusion (1781) 1781
cerebral-artery occlusion (1777) 1777
infarction, middle cerebral artery - pathology (1766) 1766
child (1756) 1756
artery occlusion (1753) 1753
brain - metabolism (1753) 1753
cell biology (1735) 1735
brain ischemia - metabolism (1729) 1729
hematology (1728) 1728
brain ischemia - complications (1726) 1726
infarction, middle cerebral artery - drug therapy (1723) 1723
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (231) 231
OISE - Stacks (13) 13
UTL at Downsview - May be requested (13) 13
UofT at Mississauga - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Holland Bloorview Kids Rehabilitation - Stacks (10) 10
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Baycrest Hospital - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
West Park Healthcare Centre - Stacks (5) 5
OISE - Lost (2) 2
Providence Healthcare - Reference (2) 2
Robarts - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (46610) 46610
Japanese (723) 723
German (638) 638
Chinese (326) 326
French (263) 263
Spanish (257) 257
Russian (87) 87
Dutch (40) 40
Korean (30) 30
Norwegian (26) 26
Polish (26) 26
Portuguese (23) 23
Italian (19) 19
Swedish (18) 18
Danish (15) 15
Finnish (13) 13
Czech (10) 10
Serbian (9) 9
Hungarian (7) 7
Turkish (7) 7
Slovak (5) 5
Hebrew (3) 3
Icelandic (3) 3
Arabic (2) 2
Croatian (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2015, Volume 373, Issue 11, pp. 1021 - 1031
Patients with acute STEMI undergoing PCI were assigned to cyclosporine or placebo. No significant between-group difference was seen in the rate of death,... 
HEART | MEDICINE, GENERAL & INTERNAL | MITOCHONDRIAL PERMEABILITY TRANSITION | PERCUTANEOUS CORONARY INTERVENTION | INJECTION | REPERFUSION INJURY | SIZE | PORE | ISCHEMIA | CARDIOPROTECTION | ASPIRATION | Enzyme Inhibitors - adverse effects | Injections, Intravenous | Double-Blind Method | Humans | Middle Aged | Mortality | Kaplan-Meier Estimate | Male | Combined Modality Therapy | Enzyme Inhibitors - administration & dosage | Cyclophilins - antagonists & inhibitors | Myocardial Infarction - therapy | Myocardial Infarction - drug therapy | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Electrocardiography | Female | Aged | Heart Failure - epidemiology | Ventricular Remodeling - drug effects | Percutaneous Coronary Intervention | Care and treatment | Usage | Angiography | Heart enlargement | Dosage and administration | Cyclosporine | Heart attack | Occlusion | Myocardial infarction | Heart | Cerebral infarction | Heart attacks | Intravenous administration | Cyclosporins | Angioplasty | Body weight | Coronary artery | Clinical trials | Angina | Patients | Clinical outcomes | Reperfusion | Ventricle | Drug therapy | Heart diseases | Pharmaceuticals | Life Sciences | Bioengineering | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The Lancet, ISSN 0140-6736, 04/2018, Volume 391, Issue 10131, pp. 1693 - 1705
Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically... 
MECHANICALLY VENTILATED PATIENTS | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | 2015 INTERNATIONAL CONSENSUS | CARDIOVASCULAR CARE SCIENCE | SURGICAL SITE INFECTION | SUPPLEMENTAL OXYGEN | ELEVATION MYOCARDIAL-INFARCTION | CARDIOPULMONARY-RESUSCITATION | PERIOPERATIVE OXYGEN | ABDOMINAL-SURGERY | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Pneumonia - therapy | Oxygen - therapeutic use | Humans | Middle Aged | Cross Infection - mortality | Male | Sepsis - complications | Conservative Treatment - methods | Oxygen - adverse effects | Cross Infection - complications | Hospital Mortality - trends | Myocardial Infarction - therapy | Oxygen - supply & distribution | Pneumonia - mortality | Aged, 80 and over | Iatrogenic Disease - epidemiology | Adult | Female | Oxygen Inhalation Therapy - methods | Length of Stay - statistics & numerical data | Oxygen Inhalation Therapy - mortality | Cross Infection - epidemiology | Morbidity - trends | Cross Infection - therapy | Pneumonia - epidemiology | Sepsis - epidemiology | Randomized Controlled Trials as Topic | Sepsis - mortality | Critical Illness - epidemiology | Myocardial Infarction - complications | Oxygen Inhalation Therapy - adverse effects | Sepsis - therapy | Critical Illness - therapy | Pneumonia - complications | Aged | Medical research | Pneumonia | Bacterial pneumonia | Mortality | Morbidity | Analysis | Cardiac patients | Medicine, Experimental | Medical care | Adults | Cross infection | Nosocomial infections | Health aspects | Quality management | Myocardial infarction | Hyperbaric oxygen therapy | Therapy | Intensive care | Prospero protein | Clinical trials | Life assessment | Systematic review | Subgroups | Habitability | Randomization | Surgery | Heart diseases | Emergency medical services | Respiratory therapy | Evaluation | Cerebral infarction | Oxygen | Stroke | Sensitivity analysis | Patients | Trauma | Disease control | Meta-analysis | Respiratory diseases | Sepsis | Infarction | Quality assessment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 17, pp. 1587 - 1597
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1287 - 1296
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 25, pp. 2419 - 2432
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 21, pp. 2205 - 2217
Immediate percutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarction. In this study, PCI that was... 
IMMEDIATE ANGIOPLASTY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | TO-BALLOON TIME | 30-DAY MORTALITY | INTRAVENOUS THROMBOLYTIC THERAPY | RISK PATIENTS | REPERFUSION THERAPY | SYMPTOM-ONSET | PRIMARY ANGIOPLASTY | FIBRINOLYTIC THERAPY | Myocardial Infarction - mortality | Myocardial Infarction - classification | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Time Factors | Electrocardiography | Female | Cerebral Infarction - chemically induced | Double-Blind Method | Kaplan-Meier Estimate | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Combined Modality Therapy | Recombinant Proteins - administration & dosage | Myocardial Infarction - complications | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Care and treatment | Abciximab | Coronary artery bypass | Comparative analysis | Health aspects | Heart attack | Angioplasty | Heart attacks | Intubation | Index Medicus | Abridged Index Medicus
Journal Article